Abstract
PURPOSE: National Surgical Adjuvant Breast and Bowel Project Protocol R-03 was designed to determine the worth of preoperative chemotherapy and radiation therapy in the management of operable rectal cancer. METHODS: Thus far, 116 patients of an eventual 900 with primary operable rectal cancer have been randomized to receive multimodality therapy to begin preoperatively (59 patients) or identical therapy beginning after curative surgery (57). All patients received seven cycles of 5-fluorouracil (FU)/leucovorin (LV) chemotherapy. Cycles 1 and 4 through 7 used a high-dose weekly FU regimen. In Cycles 2 and 3, FU and low-dose LV chemotherapy was given during the first and fifth week of radiation therapy (5,040 cGy). The preoperative arm (Group 1) received the first three cycles of chemotherapy and all radiation therapy before surgery. The postoperative arm (Group 2) received all radiation and chemotherapy after surgery. Primary study end points included disease-free survival and survival. Secondary end points included local recurrence, primary tumor response to combination therapy, tumor downstaging, and sphincter preservation. RESULTS: Overall treatment-related toxicity was similar in both groups. Although seven preoperative patients had events after randomization that precluded surgery, eight events occurred during an equivalent follow-up period in the postoperative group. No patient was deemed inoperable because of progressive local disease. Sphincter-saving surgery was intended in 31 percent of Group 1 patients and 33 percent of Group 2 patients at the time of randomization. Such surgery was actually performed in 50 percent of the preoperatively treated patients and 33 percent of the postoperatively treated patients. The use of protective colostomy in patients undergoing sphincter-sparing surgery and the development of perioperative complications in all surgical patients were similar in both groups. There was evidence of tumor downstaging in evaluable patients under-going preoperative therapy, with 8 percent of Group 1 patients having had a pathologic complete response. CONCLUSION: These data do suggest that the preoperative chemotherapy and radiation therapy regimen used are, at least, as safe and tolerable as standard postoperative treatment. There is presently a trend to tumor downstaging and sphincter preservation in the preoperative arm. Whether this arm will have greater or lesser survival and long-term toxicity awaits the completion of this relevant study.
Similar content being viewed by others
References
Freedman GM, Coia LR. Adjuvant and neoadjuvant treatment of rectal cancer. Semin Oncol 1995;22:611–24.
Rosenthal SA, Trock BJ, Coia LR. Randomized trials of adjuvant radiation therapy for rectal cancer: a review. Dis Colon Rectum 1990;33:335–43.
Horiot J-C, Bosset JF. Pre-operative radiotherapy for rectal cancer: what benefit? Which technical parameters? Eur J Cancer 1994;30A:1:597–9.
NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264: 1444–50.
Lingareddy V, Mohiuddin M, Marks G. The importance of patient selection for adjunctive postoperative radiation therapy for cancer of the rectum: patient selection in adjunctive therapy. Cancer 1994;73:1805–10.
Miller MJ, Kagan AR, Rao AR, Wollin M. An evaluation of the efficacy of postoperative irradiation in rectal adenocarcinoma. Am J Clin Oncol 1993;16:402–6.
Rider WD, Palmer JA, Mahoney LJ,et al. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977;20:335–8.
Duncan W. Adjuvant radiotherapy in rectal cancer: the MRC trials. Br J Surg 1985;72:559–62.
Roswit B, Higgins GA Jr, Keehn RJ. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer 1975;35:1597–602.
Gerard A, Buyse M, Nordlinger B,et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208:606–14.
Cedermark B, Johansson H, Rutqvist LE,et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal cancer: a prospective randomized trial. Cancer 1995;75:2269–75.
Cedermark B. The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma: a propective randomized trial [abstract]. Proc Am Soc Clin Oncol 1994;13:198.
Dahl O, Horn A, Morild I,et al. Low-dose preoperative radiation postpones recurrences inoperable rectal cancer: results of a randomized multicenter trial in Western Norway. Cancer 1990;66:2286–94.
Påhlman L, Glimelius B. Preand postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211:187–95.
Frykholm GJ, Glimelius B, Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564–72.
Douglass HO, Stablein DM, Mayer RJ. Ten years of follow-up of first generation of surgical adjuvant rectal cancer studies of the Gastrointestinal Tumor Study Group. In: Hamilton J, Elliot J, eds. NIH Consensus Development Conference: Adjuvant therapy for patients with colon and rectum cancer. Bethesda: National Institutes of Health, 1990:35–40.
Fisher B, Wolmark N, Rockette H,et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21–9.
Krook JE, Moertel CG, Gunderson LL,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15.
Fuchs CS, Mayer RJ. Adjuvant chemotherapy for colon and rectal cancer. Semin Oncol 1995;22:472–87.
Mamounas EP, Rockette H, Jones J,et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' Bversus Dukes' C colon cancer: results from four NSABP adjuvant studies (C-01, C-02, C-03, C-04) [abstract]. Proc Am Soc Clin Onc 1996;15:205.
Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–5.
Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–92.
Fisher B, Saffer E, Deutsch M. Influence of irradiation of a primary tumor on the labeling index and estrogen receptor index in a distant tumor focus. Int J Radiat Oncol Biol Phys 1986;12:879–85.
Fisher B, Saffer E, Rudock C,et al. Effect of local or systemic tratment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res 1989;49:2002–4.
Rosen G, Caparros B, Huvos AG,et al. Preoperative chemotherapy for osteogenic sarcoma. Cancer 1982;49:1221–30.
Perloff M, Lesnick GJ. Chemotherapy before and after mastectomy in stage III breast cancer. Arch Surg 1982;117:879–81.
Schick P, Goodstein J, Moor J,et al. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. J Surg Oncol 1983;22:278–82.
Leichman L, Steiger Z, Seydel HG,et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984;2:75–9.
Schuller DE, Wilson HE, Smith RE,et al. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Cancer 1983;51:15–9.
Rockette H, Deutsch M, Petrelli N,et al. Effect of postoperative radiation therapy when used with adjuvant chemotherapy in Dukes' B and C rectal cancer: results from NSABP R-02 [abstract]. Proc Am Soc Clin Oncol 1994;13:193.
Hyams DM, Mamounas E, Wolmark N,et al. The effect of postoperative radiaition therapy (RTX) used with adjuvant chemotherapy in Dukes' B and C rectal cancer: results from NSABP R-02. Absract Book: 49th Annual Cancer Syposium. Arlington Heights: Society of Surgical Oncology, 1996.
Minsky B, Cohen A, Enker W,et al. Preoperative 5-flu-orouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1994;73:273–80.
Hortobagyi GN, Ames FC, Buzdar Au,et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507–16.
Milsom JW, Lavery IC, Stolfi VM,et al. The expanding utility of endoluminal ultrasonography in the mange-ment of rectal cancer. Surgery 1992;112:832–40.
Anderson BO, Hann LE, Enker WE,et al. Transrectal ultrasonography and operative selection for early carcinoma of the rectum. J Am Coll Surg 1994;179:513–7.
Marks G, Mohiuddin M, Raknick J. New hope and promise for sphincter preservation in the management of cancer of the rectum. Semin Oncol 1991;18:383–98.
Berard P, Papillon J. Role of pre-operative irradiation for anal preservation in cancer of the low rectum. World J Surg 1992;16:502–9.
Minsky BD, Cohen AM, Enker WE,et al. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys 1992;23:387–92.
Marks G, Mohiuddin M, Masoni L. The reality of radical sphincter preservation surgery for cancer of the distal 3 cm of rectum following high-dose radiation. Int J Radiat Oncol Biol Phys 1993;27:779–83.
Minsky BD, Cohen AM, Enker WE,et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553–9.
Author information
Authors and Affiliations
Additional information
Supported by National Cancer Institute Grants U10-CA-12027 and U10-CA-37377 and American Cancer Society Grant R-13.
Read at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 9 to 14, 1996.
About this article
Cite this article
Hyams, D.M., Mamounas, E.P., Petrelli, N. et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. Dis Colon Rectum 40, 131–139 (1997). https://doi.org/10.1007/BF02054976
Issue Date:
DOI: https://doi.org/10.1007/BF02054976